drugset
drugset / Trial / NCT02353806

Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation

NCT02353806 ↗

Phase 4 Completed 16 enrolled University of Texas Southwestern Medical Center National Center for Advancing Translational Sciences (NCATS) · collab
NaSingle-groupOpen-labelTreatment

Summary

This is a phase IV prospective trial to collect and analyze information about the maternal pharmacokinetics of amlodipine besylate at the time of delivery and during postpartum lactation. The study will also evaluate amlodipine concentrations in the infants of breastfeeding mothers who are taking amlodipine besylate for treatment chronic hypertension.

Timeline

Start
2015-01
Primary completion
2016-07
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 5 mg —

Indications

hypertension, pregnancy-induced